Asthma. Asthma
Conditions
Interventions
Intervention 1: The intervention group: Take the medication montelukast to patients. Each treatment period of 3 months. Drug dosage is one capsule daily. Intervention 2: Control group: an inhaled ster
Treatment - Drugs
The intervention group: Take the medication montelukast to patients. Each treatment period of 3 months. Drug dosage is one capsule daily.
Control group: an inhaled steroid drugs to patients. Each treatment period of 3 months. Two puffs daily drug dosage
Sponsors
Vice chancellor for research Of Qom Branch Of Islamic Azad University
Eligibility
Sex/Gender
All
Age
4 Years to 11 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 4-11 years old; having asthma (according to GINA criterion); patients with mild persistent asthma (according to GINA criterion). Exclusion criteria: any medical disease that affects the study results, such as Bacterial or Viral Infections of the Respiratory Tract and uncontrolled asthma (peak expiratory flow<20%); taking antibiotics during the month before entering the study; non-compliance of taking drug: the participants’ compliance will be determined from the number of montelukasts not taken at the end of each month (montelukast has been taken for more than 24 days per month).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical signs asthma(cough, wheezing, dyspnea). Timepoint: efore intervention, the end of the first month, the end of second month, the end of the third month. Method of measurement: According to GINA questionnaire and Child ACT. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severe of Asthma. Timepoint: Before intervention, the end of the first month, the end of second month, the end of the third month. Method of measurement: According to need for treatment as recommended by GINA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Gholamzadeh Baeis
Qom Branch Of Islamic Azad University
Outcome results
None listed